Dark

WST
West Pharmaceutical Services, Inc.
stock NYSE

Market Open

Jun 30, 2026 11:10:18 AM EDT

354.83USD+0.042%(+0.15)144,632

330.39Bid 374.50Ask 44.11Spread

Pre-market

0.00USD-100.000%(-354.68)0

After-hours

Jun 29, 2026 4:00:30 PM EDT

354.68USD+0.011%(+0.04)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 25, 2022

06:04AM EST West Pharma Enters Supply And Technology Agreement With Corning RTTNews

06:03AM EST West Announces Collaboration With Corning In Pharmaceutical Injectable Drug Delivery Benzinga

06:01AM EST West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable PR Newswire

Jan 13, 2022

11:50AM EST West Pharmaceutical Servs's Ex-Dividend Date Is Monday, Here's What You Need To Know Benzinga

Jan 5, 2022

04:31PM EST West Pharmaceutical Services, Inc. Announces p To 650K Share Buyback For 2022 Benzinga

04:30PM EST West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program PR Newswire

Dec 27, 2021

04:30PM EST West to Participate in Upcoming Investor Conference PR Newswire

Nov 17, 2021

12:14PM EST $1000 Invested In This Stock Over The Last 15 Years, Would Be Worth This Much Benzinga

Nov 11, 2021

04:30PM EST West to Participate in Upcoming Investor Conferences PR Newswire

Nov 9, 2021

01:08PM EST Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years Benzinga

10:47AM EST When Winning Streaks Stop: Trying To Beat The Market By Buying Stocks Like Tesla Benzinga

Oct 28, 2021

07:18AM EDT West Pharmaceutical Services: Q3 Earnings Insights Benzinga

06:04AM EDT West Pharmaceutical Servs Raises FY21 Adj. EPS Guidance From $8.05-$8.20 To $8.40-$8.50 vs $8.21 Est.; Raises Sales Guidance From $2.76B-$2.785B To $2.8B-$2.81B vs $2.8B Est. Benzinga

06:02AM EDT West Pharmaceutical Servs Q3 Adj. EPS $2.06 Beats $1.80 Estimate, Sales $706.50M Beat $687.09M Estimate Benzinga

06:01AM EDT West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 PR Newswire

04:08AM EDT Earnings Scheduled For October 28, 2021 Benzinga

Oct 27, 2021

11:54AM EDT West Pharmaceutical Servs's Earnings: A Preview Benzinga

Oct 25, 2021

06:01AM EDT West's NovaGuard(r) SA Pro Safety System Recognized for Best Technologies PR Newswire

Oct 19, 2021

06:01AM EDT West Introduces DeltaCube(tm) Modeling Platform and NovaGuard(r) SA Pro Safety PR Newswire

Oct 14, 2021

06:01AM EDT West to Host Third-Quarter 2021 Conference Call PR Newswire

Sep 10, 2021

08:00AM EDT The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test Benzinga

Sep 9, 2021

08:17AM EDT The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization Benzinga

Sep 3, 2021

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

Sep 1, 2021

07:32AM EDT The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

Aug 24, 2021

08:09AM EDT The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal Benzinga

Aug 23, 2021

04:30PM EDT West Elects New Director to the Board PR Newswire

Aug 20, 2021

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 11, 2021

08:14AM EDT The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering Benzinga

Aug 10, 2021

02:42PM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Aug 6, 2021

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

Aug 3, 2021

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

Jul 30, 2021

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

07:44AM EDT 10 Biggest Price Target Changes For Friday Benzinga

05:55AM EDT Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $475 Benzinga

Jul 29, 2021

08:18AM EDT The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs Benzinga

07:21AM EDT Recap: West Pharmaceutical Services Q2 Earnings Benzinga

06:28AM EDT West Pharmaceutical Services Q2 Reported EPS Up 104% To $2.47 RTTNews

06:08AM EDT West Pharmaceutical Services Raises FY21 Adj. EPS Guidance From $6.95-$7.10 To $8.05-$8.20 vs $7.14 Est., Raises Sales Guidance From $2.63B-$2.655B To $2.760B-$2.785B vs $2.68B Est. Benzinga

06:06AM EDT West Pharmaceutical Servs Q2 Adj. EPS $2.46 Beats $1.74 Estimate, Sales $723.60M Beat $669.38M Estimate Benzinga

06:01AM EDT West Announces Second-Quarter 2021 Results PR Newswire

04:23AM EDT Earnings Scheduled For July 29, 2021 Benzinga

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 19, 2021

10:40AM EDT Ex-Dividend Date Insight: West Pharmaceutical Servs Benzinga

Jul 15, 2021

06:01AM EDT West to Host Second-Quarter 2021 Conference Call PR Newswire

Jul 13, 2021

08:05AM EDT The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data Benzinga

Jul 12, 2021

10:14AM EDT Stocks That Hit 52-Week Highs On Monday Benzinga

Jul 9, 2021

07:36AM EDT The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO Benzinga

Jul 8, 2021

07:45AM EDT The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test Benzinga

Jul 7, 2021

07:41AM EDT The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend Benzinga

Jun 29, 2021

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

Jun 25, 2021

07:32AM EDT The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs Benzinga

Jun 24, 2021

08:12AM EDT The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO Benzinga

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

Jun 18, 2021

07:46AM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Jun 2, 2021

08:20AM EDT The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements Benzinga

May 27, 2021

08:24AM EDT The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs Benzinga

May 26, 2021

07:33AM EDT The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing Benzinga

May 25, 2021

07:53AM EDT The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal Benzinga

06:01AM EDT West Announces Participation in Upcoming Investor Conference PR Newswire

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 5, 2021

06:26AM EDT West Pharma Declares Q3 Dividend Of $0.17/Shr; Record July 21/August 4 RTTNews

06:01AM EDT West Announces Third-Quarter Dividend and Participation in Upcoming Investor PR Newswire

May 4, 2021

08:10AM EDT The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data Benzinga

Apr 30, 2021

07:31AM EDT The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs Benzinga

Apr 29, 2021

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

07:18AM EDT West Pharmaceutical: Q1 Earnings Insights Benzinga

06:30AM EDT West Pharma Q1 Reported EPS $1.99; Adj EPS $2.05 RTTNews

06:10AM EDT UPDATE: West Pharma Raises FY21 Net Sales Guidance From $2.5B-$2.525B To $2.63B-$2.655B vs $2.58B Estimate, Adj. EPS From $6-$6.15 To $6.95-$7.10 vs $6.15 Est. Benzinga

06:09AM EDT West Pharmaceutical Servs Q1 Adj. EPS $2.05 Beats $1.43 Estimate, Sales $670.70M Beat $611.39M Estimate; Raises Guidance Benzinga

06:01AM EDT West Announces First-Quarter 2021 Results PR Newswire

04:10AM EDT Earnings Scheduled For April 29, 2021 Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 23, 2021

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 22, 2021

08:09AM EDT The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs Benzinga

Apr 21, 2021

07:31AM EDT The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue Benzinga

Apr 20, 2021

08:07AM EDT The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex Benzinga

Apr 19, 2021

10:20AM EDT Understanding West Pharmaceutical Servs's Ex-Dividend Date Benzinga

Apr 15, 2021

06:01AM EDT West to Host First-Quarter 2021 Conference Call PR Newswire

Mar 17, 2021

06:01AM EDT West Announces Participation in Upcoming Investor Conference PR Newswire

Feb 24, 2021

04:31PM EST West Announces Second-Quarter 2021 Dividend PR Newswire

Feb 18, 2021

10:24AM EST West Pharmaceutical Services shares were trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY21 EPS and sales guidance above analyst estimates. Benzinga

08:14AM EST The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout Benzinga

07:40AM EST West Pharmaceutical: Q4 Earnings Insights Benzinga

06:06AM EST West Pharmaceutical Services Sees FY21 EPS $6.00-$6.15 Vs. $5.12 Est., Sales $2.5B-$2.525B Vs. $2.35B Est. Benzinga

06:05AM EST West Pharmaceutical Servs Q4 EPS $1.34 Beats $1.12 Estimate, Sales $580.20M Beat $543.67M Estimate Benzinga

06:01AM EST West Announces Fourth-Quarter and Full-Year 2020 Results PR Newswire

04:28AM EST Earnings Scheduled For February 18, 2021 Benzinga

Feb 4, 2021

06:01AM EST West to Host Fourth-Quarter and Full-Year 2020 Conference Call PR Newswire

Jan 8, 2021

07:25AM EST The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga

Dec 9, 2020

06:09AM EST West Pharmaceutical Services Declares Q1 Dividend Of $0.17/Shr; Announces 2021 Share Repurchase Program Of 631K Shares RTTNews

06:06AM EST West Pharmaceutical Services Announces 613K Share Buyback Benzinga

06:01AM EST West Announces First-Quarter 2021 Dividend, 2021 Share Repurchase Program and PR Newswire

Nov 10, 2020

09:31AM EST Benzinga's Top Upgrades, Downgrades For November 10, 2020 Benzinga

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Nov 9, 2020

04:30PM EST West Appoints Kimberly Banks MacKay as Senior Vice President General Counsel PR Newswire

Nov 6, 2020

10:14AM EST Ex-Dividend Date Insight: West Pharmaceutical Servs Benzinga

Oct 28, 2020

07:03AM EDT Cramer Shares His Thoughts On Slack, Gilead And More Benzinga

06:01AM EDT West Announces Increase to Fourth-Quarter 2020 Dividend PR Newswire

Oct 25, 2020

02:38PM EDT Last Week's Notable Insider Buys: Del Taco, First American And More Benzinga

Oct 22, 2020

05:07PM EDT West Reports FDA 510(k) Clearance, Launch Of Vial2Bag Advanced 20mm Admixture Device Benzinga

05:00PM EDT West Launches New Vial2Bag Advanced(tm) 20mm Admixture Device PR Newswire

07:52AM EDT The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat Benzinga

07:20AM EDT West Pharmaceutical: Q3 Earnings Insights Benzinga

06:18AM EDT West Pharmaceutical Servs Raises Its FY20 EPS From $4.15-$4.25 To $4.50-$4.55 Vs $4.25 Estimates, Sales From $2.035B-$2.055B To $2.1B-$2.11B Vs $2.05B Estimates Benzinga

06:15AM EDT West Pharmaceutical Servs Q3 EPS $1.16 Beats $0.99 Estimate, Sales $548.00M Beat $510.14M Estimate Benzinga

06:09AM EDT West Pharmaceutical Services Q3 Reported EPS $1.09, Adjusted EPS $1.15 RTTNews

06:01AM EDT West Announces Third-Quarter 2020 Results PR Newswire

04:38AM EDT Earnings Scheduled For October 22, 2020 Benzinga

Oct 14, 2020

10:01AM EDT Benzinga's Top Upgrades, Downgrades For October 14, 2020 Benzinga

08:36AM EDT Stephens & Co. Initiates Coverage On West Pharmaceutical Servs with Equal-Weight Rating, Announces Price Target of $300 Benzinga

Oct 8, 2020

06:01AM EDT West to Host Third-Quarter 2020 Conference Call PR Newswire

Aug 31, 2020

10:26AM EDT Shares of West Pharmaceutical Services Inc. (WST), which have been trading in range of $124.53 - $284.95 for the past one year, reached 52-week high Monday morning. WST is currently trading at $281.33, up $9.74 or 3.59% in the regular session. RTTNews

Jul 23, 2020

07:15AM EDT West Pharmaceutical Services: Q2 Earnings Insights Benzinga

06:20AM EDT West Raises FY20 Guidance: Adj. EPS From $3.52-$3.62 To $4.15-$4.25 vs $3.64 Estimate, Sales From $1.95B-$1.97B To $2.035B-$2.055B vs $1.97B Est. Benzinga

06:18AM EDT West Pharmaceutical Servs Q2 Adj. EPS $1.25 Beats $0.88 Estimate, Sales $527.20M Beat $490.58M Estimate Benzinga

06:09AM EDT West Pharmaceutical Services Q2 Reported EPS Up 38% To $1.21, Adj. EPS Up 40% To $1.25 RTTNews

06:01AM EDT West Announces Second-Quarter 2020 Results PR Newswire

04:30AM EDT Earnings Scheduled For July 23, 2020 Benzinga

Jul 15, 2020

06:08AM EDT West Pharmaceutical Services Declares Q3 Dividend Of $0.16/Shr; Record July 29/payable August 5 RTTNews

06:00AM EDT West Announces Third-Quarter 2020 Dividend PR Newswire